Researchers from the Université de Montréal in Canada have created and verified a new class of DNA-based drug transporters that are 20,000 times smaller than a human hair and could enhance cancer treatment and other diseases.
Optimal Dosing at All Times: A Medical Challenge
Providing and maintaining a therapeutic drug dosage during treatment is one of the most important factors in the successful treatment of disease. Overexposure raises side effects whereas sub-optimal therapeutic exposure decreases effectiveness and often results in drug resistance.
Modern medicine continues to struggle with maintaining the ideal drug concentration level in the blood. Patients must take numerous doses at regular intervals since most drugs degrade quickly, and they frequently forget to do so. The drug concentration in each patient’s blood also varies considerably because each has a unique pharmacokinetic profile.
Alexis Vallée-Bélisle, an Associate Professor of Chemistry at the Université de Montréal and a specialist in bio-inspired nanotechnologies, began to investigate how biological systems control and maintain the concentration of biomolecules after noticing that only about 50% of cancer patients receive the ideal drug dosage during certain chemotherapy.
We have found that living organisms employ protein transporters that are programmed to maintain precise concentration of key molecules such as thyroid hormones, and that the strength of the interaction between these transporters and their molecules dictates the precise concentration of the free molecule.
Alexis Vallée-Bélisle, Associate Professor, Chemistry, Université de Montréal
This simple and direct notion prompted Valléé-Belisle and his research group to create synthetic drug transporters that mimic the natural effect of preserving a precise drug concentration during treatment. Valléé-Belisle holds a Canada Research Chair in bioengineering and bionanotechnology.
Arnaud Desrosiers, a Ph.D. student at UdeM, is the study’s first author. He discovered and created two DNA transporters: one for the antimalarial quinine and the other for the chemical doxorubicin, frequently used to treat leukemia and breast cancer.
He went on to show how these synthetic transporters could be easily set up to deliver and maintain any desired drug concentration.
More interestingly, we also found that these nanotransporters could also be employed as a drug reservoir to prolong the effect of the drug and minimize its dosage during treatment. Another impressive feature of these nanotransporters is that they can be directed to specific parts of the body where the drug is most needed – and that, in principle, should reduce most side effects.
Arnaud Desrosiers, Study First Author and PhD Student, Université de Montréal
Nanotreated Mice: Reduced Cardiotoxicity
The researchers collaborated with Jeanne Leblond-Chain, a pharmacist at the Université de Bordeaux in France, Luc DesGroseillers, a biochemist at the Université de Montréal, Jérémie Berdugo, a pathologist at the Université de Montréal, Céline Fiset, a pharmacist at the Montreal Heart Institute, and Vincent De Guire, a clinical biochemist at the Maisonneuve-Rosemont Hospital, which is affiliated with Université de Montréal, to show the effectiveness of these nanotransporters.
The team found that a particular drug-transporter formulation enables doxorubicin to be kept in circulation and significantly inhibits its diffusion toward important organs like the heart, lungs, and pancreas.
This formulation kept doxorubicin in the blood of mice 18 times longer than usual and minimized cardiotoxicity, keeping the mice healthier as indicated by their normal weight gain.
Vallée-Bélisle stated, “Another great property of our nanotransporters is their high versatility. For now, we have demonstrated the working principle of these nanotransporters for two different drugs. But thanks to the high programmability of DNA and protein chemistries, one can now design these transporters to precisely deliver a wide range of therapeutic molecules.”
He further added, “Additionally, these transporters could also be combined with human-designed liposomic transporters that are now being employed to deliver drugs at various rates.”
A Clinical Study for Blood Cancers?
The scientists are now eager to confirm if their discovery works clinically. They believe their doxorubicin nanotransporter could be useful in treating blood cancers since it is designed to keep the drug in blood circulation as effectively as possible.
“We envision that similar nanotransporters may also be developed to deliver drugs to other specific locations in the body and maximize the presence of the drug at tumor sites. This would drastically improve the efficiency of drugs as well as decrease their side effects.”
The National Science and Engineering Research Council of Canada, the Canada Research Chairs, Les Fonds de recherche du Québec – Nature et technologies, and Le regroupement québécois de research sur la fonction, l’ingénierie et les applications des protéines (PROTEO) provided funding for this study.

News
Nasal Vaccines: Stopping the COVID-19 Virus Before It Reaches the Lungs
The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to improve [...]
NASA Tracking a Huge, Growing Anomaly in Earth’s Magnetic Field – with video
NASA is actively monitoring a strange anomaly in Earth's magnetic field: a giant region of lower magnetic intensity in the skies above the planet, stretching out between South America and southwest Africa. This vast, developing [...]
New, Better Models Show How Infectious Diseases Like COVID-19 Spread
Infectious diseases such as COVID-19 can spread rapidly across the globe. Models that can predict how such diseases spread will strengthen national surveillance systems and improve public health decision-making. The COVID-19 pandemic has emphasized the [...]
Human Antibodies Discovered That Can Block Multiple Coronaviruses Including COVID-19
Results from a Scripps Research and UNC team pave the way for a vaccine and therapeutic antibodies that could be stockpiled to fight future coronavirus pandemics. A team of scientists from Scripps Research and [...]
Nanotechnology could be used to treat lymphedema
The human body is made up of thousands of tiny lymphatic vessels that ferry white blood cells and proteins around the body, like a superhighway of the immune system. It's remarkably efficient, but if [...]
DNA Nanotechnology Tools – From Design to Applications
Suite of DNA nanotechnology devices engineered to overcome specific bottlenecks in the development of new therapies, diagnostics, and understanding of molecular structures. DNA nanostructures with their potential for cell and tissue permeability, biocompatibility, and [...]
Regenerating bone with deer antler stem cells
Scientists from a collection of Chinese research institutions collaborated on a study of organ regeneration in mammals, finding deer antler blastema progenitor cells are a possible source of conserved regeneration cells in higher vertebrates. [...]
AI Takes On Cancer: Analysis of Mutations Could Lead to Improved Therapy
Cancer is a complex and diverse disease, and its range of associated mutations is vast. The combination of these genomic changes in an individual is referred to as their “mutational landscape.” These landscapes vary [...]
Exposing tumours to bacteria converts immune cells to cancer killers
New research on inflammation could lead to better treatments to improve outcomes for people with advanced or previously untreatable cancers. Introducing bacteria to a tumour’s microenvironment creates a state of acute inflammation that triggers [...]
Smart nanotechnology for more accurate delivery of insulin
More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to measure their glucose levels could be a step closer thanks to a Monash University-led project. Published [...]
Efficiently Harvesting Rare Earth Elements From Wastewater Using Exotic Bacteria
The novel strains of cyanobacteria exhibit a fast and efficient “biosorption” of rare earth elements, making recycling possible. Rare earth elements (REEs) are a set of 17 metallic elements that possess similar chemical properties. [...]
Resisting Treatment: Cancer Cells Shrink or Super-Size To Survive
A new approach to image analysis has uncovered how cancer cells manipulate their size as a means of resisting treatment. Researchers have discovered that cancer cells are capable of either shrinking or super-size themselves [...]
New Research Explains Why Children Avoid Severe COVID-19 Symptoms
According to new research, children exhibit a robust initial immune response to the coronavirus, however, they are unable to transfer this response to long-lasting memory T cells like adults do. Researchers led by scientists [...]
Scientists Unravel Protein Map of Mitochondria
A new study sheds light on the organization of proteins within mitochondria. Mitochondria, the “powerhouses” of cells, play a crucial role in the energy production of organisms and are involved in various metabolic and [...]
Mystifying Trapping Phenomenon: A Surprising Way To Catch a Microparticle
New insights could advance microfluidics and drug delivery systems. New study finds obstacles can trap rolling microparticles in fluid Through simulations and experiments, physicists attribute the trapping effect to stagnant pockets of fluid, created [...]
New Alzheimer’s Treatment: Blocking T Cells To Prevent Neurodegeneration
Findings, in mice, open up drug development possibilities for brain diseases linked to tau protein. Nearly two dozen experimental therapies targeting the immune system are in clinical trials for Alzheimer’s disease, a reflection of the growing [...]